Np mrd loader

Record Information
Version1.0
Created at2021-06-21 00:48:36 UTC
Updated at2021-06-30 00:19:02 UTC
NP-MRD IDNP0043389
Secondary Accession NumbersNone
Natural Product Identification
Common Nameyunnanterpene F
Provided ByJEOL DatabaseJEOL Logo
Description yunnanterpene F is found in Cimicifuga yunnanensis. It was first documented in 2002 (PMID: 33651529). Based on a literature review very few articles have been published on (1R,3R,3'R,4R,4'S,5R,6R,8S,10S,12S,13S,14S,16R,18S,21R)-4,4',6,12,17,17-hexamethyl-18-{[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]Docosane-8,2'-oxolane]-3,3',4',14-tetrol (PMID: 33079503) (PMID: 26389513) (PMID: 26389498) (PMID: 26389454).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC35H56O11
Average Mass652.8220 Da
Monoisotopic Mass652.38226 Da
IUPAC Name(1R,3R,3'R,4R,4'S,5R,6R,8S,10S,12S,13S,14S,16R,18S,21R)-4,4',6,12,17,17-hexamethyl-18-{[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0^{1,21}.0^{4,12}.0^{5,10}.0^{16,21}]docosane-8,2'-oxolane]-3,3',4',14-tetrol
Traditional Name(1R,3R,3'R,4R,4'S,5R,6R,8S,10S,12S,13S,14S,16R,18S,21R)-4,4',6,12,17,17-hexamethyl-18-{[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0^{1,21}.0^{4,12}.0^{5,10}.0^{16,21}]docosane-8,2'-oxolane]-3,3',4',14-tetrol
CAS Registry NumberNot Available
SMILES
[H]O[C@]1([H])[C@](O[H])(C([H])([H])[H])C([H])([H])O[C@@]11O[C@@]2([H])C([H])([H])[C@@]3(C([H])([H])[H])[C@]4([H])[C@@]([H])(O[H])C([H])([H])[C@]5([H])[C@]6(C([H])([H])[C@@]46C([H])([H])[C@@]([H])(O[H])[C@]3(C([H])([H])[H])[C@@]2([H])[C@]([H])(C([H])([H])[H])C1([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[C@]1([H])OC([H])([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H])C5(C([H])([H])[H])C([H])([H])[H]
InChI Identifier
InChI=1S/C35H56O11/c1-16-10-35(28(41)31(5,42)15-44-35)46-19-11-30(4)26-17(36)9-20-29(2,3)22(45-27-25(40)24(39)18(37)13-43-27)7-8-33(20)14-34(26,33)12-21(38)32(30,6)23(16)19/h16-28,36-42H,7-15H2,1-6H3/t16-,17+,18+,19+,20+,21-,22+,23+,24+,25-,26+,27+,28-,30+,31+,32-,33-,34+,35+/m1/s1
InChI KeyBURFZMFSWQCUCA-QTBRGZRPSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Actaea yunnanensisJEOL database
    • Nian, Y., et al, J. Nat. Prod. 76, 896 (2013)
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0.61ALOGPS
logP0.2ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)11.87ChemAxon
pKa (Strongest Basic)-0.31ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count11ChemAxon
Hydrogen Donor Count7ChemAxon
Polar Surface Area178.53 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity162.99 m³·mol⁻¹ChemAxon
Polarizability71.25 ųChemAxon
Number of Rings8ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound71713541
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Authors unspecified: Curcumin (Curcuma, Turmeric) and Cancer (PDQ(R)): Health Professional Version. 2002. [PubMed:33651529 ]
  2. Authors unspecified: Cancer Therapy Interactions With Foods and Dietary Supplements (PDQ(R)): Health Professional Version. 2002. [PubMed:33079503 ]
  3. Authors unspecified: Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ(R)): Health Professional Version. 2002. [PubMed:26389513 ]
  4. Authors unspecified: Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389498 ]
  5. Authors unspecified: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389454 ]
  6. Nian, Y., et al. (2013). Nian, Y., et al, J. Nat. Prod. 76, 896 (2013). J. Nat. Prod..